Global Tensions Simmer as Philips Posts Mixed Q3, China Eases Nexperia Export Ban, and South Korea Pursues Nuclear Submarines

Philips Q3 Performance - Koninklijke Philips N.V. reported an Adjusted EBITA of €531 million for Q3 2025, exceeding analyst estimates of €486.1 million, driven by favorable mix effects and productivity measures [2][3] - The adjusted EBITA margin improved by 50 basis points to 12.3% [2] - Comparable order intake grew by 8%, particularly strong in North America [2] Sales Performance - Philips' sales for the quarter were €4.30 billion, slightly below the estimated €4.33 billion [3] - Comparable sales growth was recorded at 3.3%, falling short of the 3.57% estimate [3] - Despite the sales miss, Philips maintained its full-year 2025 outlook, expecting the adjusted EBITA margin to be at the upper end of the 11.3% to 11.8% range [3] Nexperia Dispute - China's Ministry of Commerce announced export exemptions for eligible Nexperia shipments, easing tensions in the semiconductor supply chain [4][5] - This decision followed high-level diplomatic engagements, including discussions between U.S. President Donald Trump and Chinese President Xi Jinping [5] South Korea's Nuclear Submarine Plans - South Korea is advancing its plans to develop nuclear-powered submarines by the mid-2030s, contingent on securing U.S. approval for nuclear fuel supply [6][8] - U.S. President Trump indicated approval for South Korea to build submarines, with a condition for construction in a U.S. shipyard [7][8] - South Korean officials emphasized the primary request was for nuclear fuel supply to enhance self-reliant defense capabilities against North Korea [8]